SUN-LB002 CYP11A1 Inhibition as a Therapeutic Approach for the Treatment of Castration Resistant Prostate Cancer

por Oksala, Riikka, Karimaa, Mari, Riikonen, Reetta, Räsänen, Kati, Ramela, Meri, Vehmaan-Kreula, Pirjo, Rummakko, Petteri, Wohlfahrt, Gerd, Mustonen, Mika
Publicado 2019

Phase I/IIa, open-label, multicentre study to evaluate the optimal dosing and safety of ODM-203 in patients with advanced or metastatic solid tumours

por Bono, Petri, Massard, Christophe, Peltola, Katriina J, Azaro, Analía, Italiano, Antoine, Kristeleit, Rebecca S, Curigliano, Giuseppe, Lassen, Ulrik, Arkenau, Hendrik-Tobias, Hakulinen, Pasi, Garratt, Chris, Ikonen, Tarja, Mustonen, Mika V J, Rodon, Jordi A
Publicado 2020

High intratumoral dihydrotestosterone is associated with antiandrogen resistance in VCaP prostate cancer xenografts in castrated mice

por Huhtaniemi, Riikka, Sipilä, Petra, Junnila, Arttu, Oksala, Riikka, Knuuttila, Matias, Mehmood, Arfa, Aho, Eija, Laajala, Teemu D., Aittokallio, Tero, Laiho, Asta, Elo, Laura, Ohlsson, Claes, Thulin, Malin Hagberg, Kallio, Pekka, Mäkelä, Sari, Mustonen, Mika V.J., Poutanen, Matti
Publicado 2022